阿特苏纳酸诱导黑色素瘤细胞铁亡,并通过向Ido1增强抗瘤免疫力
Wuyi Liu1, Huyue Zhou1, Wenjing Lai1
1Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Cell communication and signaling : CCS
|July 26, 2024
概括
阿特苏纳酸 (ART) 通过诱导细胞死亡 (ferroptosis) 和激活免疫细胞来抑制黑色素瘤. 这种天然化合物准Ido1,为黑色素瘤治疗提供了一种新的方法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑色素瘤仍然是一个重大的健康挑战,治疗选择有限.
- 阿尔特苏纳酸 (ART) 是Artemisia annua的衍生物,已经显示出潜在的作用,但需要进一步对抗黑色素瘤功效进行机制研究.
研究的目的:
- 为了阐明阿特苏纳酸 (ART) 的抗黑色素瘤机制.
- 研究ART对黑色素瘤细胞增殖,铁亡和CD8+T细胞激活的影响.
- 探索ART作为Ido1抑制剂在黑色素瘤治疗中的潜力.
主要方法:
- 进行了体外和体内研究.
- 进行了黑色素瘤细胞增殖和铁亡试验.
- 机制研究涉及分析与Ido1,Hic1,Hmox1和PD1相关的基因表达和蛋白质相互作用.
主要成果:
- ART显著抑制了黑色素瘤细胞的增殖,并诱导了铁亡.
- 在黑色素瘤细胞中,ART直接向Ido1,抑制Hic1介导的Hmox1转录.
- 通过向Ido1,ART激活CD8+T细胞,增加托水平并抑制PD1转录.
结论:
- 通过双重机制,ART表现出强大的抗黑色素瘤活性:诱导黑色素瘤细胞铁亡并增强CD8+ T细胞介导免疫力.
- 用ART准Ido1为黑色素瘤提供了一个新的治疗策略.
- 在临床前模型和临床环境中,ART在抗黑色素瘤方面表现出协同效果.
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


